Want to see SE:QCORE full AI Analyst Report?
QCORE Stock Chart & Stats
kr0.50
-kr0.12(-3.11%)
At close: 4:00 PM EST
kr0.50
-kr0.12(-3.11%)
Day’s Range― - ―
52-Week Rangekr0.21 - kr1.70
Previous CloseN/A
Volume1.64K
Average Volume (3M)106.36K
Market Cap
kr16.22M
Enterprise Valuekr18.38
Total Cash (Recent Filing)kr2.97M
Total Debt (Recent Filing)kr1.40M
Price to Earnings (P/E)―
Beta0.20
Next Earnings
Sep 09, 2026EPS EstimateN/A
Next Dividend Ex-DateN/A
Dividend YieldN/A
Share Statistics
EPS (TTM)-1.77
Shares Outstanding42,900,500
10 Day Avg. Volume135,027
30 Day Avg. Volume106,359
Financial Highlights & Ratios
PEG Ratio<0.01
Price to Book (P/B)0.38
Price to Sales (P/S)2.07
P/FCF Ratio-1.11
Enterprise Value/Market CapN/A
Enterprise Value/RevenueN/A
Enterprise Value/Gross ProfitN/A
Enterprise Value/EbitdaN/A
Forecast
1Y Price TargetN/A
Price Target UpsideN/A
Rating ConsensusN/A
Number of Analyst Covering0
EPS Forecast (FY)N/A
Revenue Forecast (FY)N/A
Bulls Say, Bears Say
Bulls Say
Software Licensing Revenue ModelA core software-licensing/subscription model creates durable, repeatable revenue tied to seat counts and renewals. For life-science tools this model supports predictable lifecycle revenue, customer stickiness via datasets and workflows, and scalable margins if adoption grows.
Niche Bioinformatics Product-market FitQlucore serves a structurally growing market: omics and data-driven research. Specialized visualization/analysis software addresses a persistent research workflow need, offering differentiation versus generalist tools and positioning the company to benefit from continued investment in genomics and diagnostics.
Low Financial LeverageVery low debt reduces insolvency and interest burden risk, preserving financial optionality. This structural strength gives the company time to execute turnaround or raise capital without immediate refinancing pressure, lowering the chance of forced deleveraging during continued losses.
Bears Say
Sustained UnprofitabilityMulti-year net losses and widening operating deficits erode equity and indicate the core business is not yet profitable. Persisting unprofitability threatens long-term viability absent structural margin improvement, making the company reliant on external capital and increasing dilution or financing risk.
Contracting Revenue TrendDeclining top-line over successive years signals loss of market traction or customer churn. For a software licensing business, continued revenue contraction undermines economies of scale, limits ability to cover fixed R&D and support costs, and impedes path to sustainable profitability.
Weak Cash Generation And Negative FCFPersistent negative operating and free cash flow restrict ability to self-fund growth or product investment. Even with a modest improvement in 2026, continued cash burn increases dependency on external financing, raising execution risk and potential dilution until cash generation turns positive.
QCORE FAQ
What was Qlucore AB’s price range in the past 12 months?
Qlucore AB lowest stock price was kr0.21 and its highest was kr1.70 in the past 12 months.
What is Qlucore AB’s market cap?
Qlucore AB’s market cap is kr16.22M.
When is Qlucore AB’s upcoming earnings report date?
Qlucore AB’s upcoming earnings report date is Sep 09, 2026 which is in 39 days.
How were Qlucore AB’s earnings last quarter?
Qlucore AB released its earnings results on May 28, 2026. The company reported -kr0.079 earnings per share for the quarter, missing the consensus estimate of N/A by -kr0.079.
Is Qlucore AB overvalued?
According to Wall Street analysts Qlucore AB’s price is currently Overvalued.
Does Qlucore AB pay dividends?
Qlucore AB does not currently pay dividends.
What is Qlucore AB’s EPS estimate?
Qlucore AB’s EPS estimate for its next earnings report is not yet available.
How many shares outstanding does Qlucore AB have?
Qlucore AB has 42,900,500 shares outstanding.
What happened to Qlucore AB’s price movement after its last earnings report?
Qlucore AB reported an EPS of -kr0.079 in its last earnings report, missing expectations of N/A. Following the earnings report the stock price went down -7.708%.
Which hedge fund is a major shareholder of Qlucore AB?
Currently, no hedge funds are holding shares in SE:QCORE
What is the TipRanks Smart Score and how is it calculated?
Smart Score combines eight research factors - such as analyst recommendations, hedge fund trends, and technical indicators - to measure a stock’s outlook. These signals are unified into a single score that reflects bullish or bearish momentum. See detailed methodology
Company Description
Qlucore AB
Based in Lund, Sweden, Qlucore AB (publ) delivers advanced bioinformatics data analysis tools for global application in both scientific research and accurate medical diagnostics. Its product suite includes Qlucore Omics Explorer, an AI-powered bioinformatics software designed for research across various sectors such as life science, biotechnology, food, plant industries, and academia. Additionally, the company offers Qlucore Diagnostics, a specialized software platform for multi-omics companion and precision diagnostics, as well as Qlucore Insights, which facilitates the analysis of clinical data. Qlucore was established in 2007.
Technical Analysis
Divio Technologies AB Class B
―
Flowscape Technology AB
―
Safeture AB
―
Generic Sweden AB
―
―